Your browser doesn't support javascript.
loading
Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Zjablovskaja, Polina; Kardosova, Miroslava; Danek, Petr; Angelisova, Pavla; Benoukraf, Touati; Wurm, Alexander A; Kalina, Tomas; Sian, Stephanie; Balastik, Martin; Delwel, Ruud; Brdicka, Tomas; Tenen, Daniel G; Behre, Gerhard; Fiore, Fréderic; Malissen, Bernard; Horejsi, Vaclav; Alberich-Jorda, Meritxell.
Afiliación
  • Zjablovskaja P; Department of Hemato-Oncology, Institute of Molecular Genetics of the ASCR, Videnska 1083, Prague 142 20, Prague 4, Czech Republic.
  • Kardosova M; Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, V Uvalu 84, Praha, 150 06, Czech Republic.
  • Danek P; Department of Hemato-Oncology, Institute of Molecular Genetics of the ASCR, Videnska 1083, Prague 142 20, Prague 4, Czech Republic.
  • Angelisova P; Department of Hemato-Oncology, Institute of Molecular Genetics of the ASCR, Videnska 1083, Prague 142 20, Prague 4, Czech Republic.
  • Benoukraf T; Department of Molecular Immunology, Institute of Molecular Genetics of the ASCR, Videnska 1083, Prague, 142 20, Czech Republic.
  • Wurm AA; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Kalina T; Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany.
  • Sian S; Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, V Uvalu 84, Praha, 150 06, Czech Republic.
  • Balastik M; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Delwel R; Department of Molecular Neurobiology, Institute of Physiology of the ASCR, Videnska 1083, Prague, 142 20, Czech Republic.
  • Brdicka T; Department of Hematology, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015 CN, The Netherlands.
  • Tenen DG; Department of Leukocyte Signalling, Institute of Molecular Genetics of the ASCR, Videnska 1083, Prague, 142 20, Czech Republic.
  • Behre G; Cancer Science Institute, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
  • Fiore F; Department Hematology/Oncology, Harvard Stem Cell Institute, Harvard Medical School, 3 Blackfan Circle, Boston, 02115, MA, USA.
  • Malissen B; Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany.
  • Horejsi V; Centre d'Immunophénomique, Aix Marseille Université, Inserm, CNRS, Marseille, F-13288, France.
  • Alberich-Jorda M; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, F-13288, France.
Cell Death Differ ; 26(1): 198, 2019 Jan.
Article en En | MEDLINE | ID: mdl-29991745
Since publication of this article, the authors identified an error in the acknowledgments section. The original sentence in acknowledgments reads as follows.
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Death Differ Año: 2019 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Death Differ Año: 2019 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Reino Unido